Fortis Frontier PLC

8.20pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:FORFHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR (29.91%)
Div yield —
ROE (15.66%)
Medical Devices
Beta (5Y) 0.58
PE TTM —
TSR TTM (8.89%)
Mkt cap £2.645M
ROIC (8.43%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
8.16p
(0.52%)
(71.16%)
Sell 4|0|8|0|6
4Q25
1Q26
2Q26
3Q26
Earnings per share£
0.09
0.09
0.09
0.09
16.56%
14.01%
12.19%
10.43%
Revenue£M
0.128
0.131
0.134
0.142
7.54%
6.91%
11.25%
11.59%
Peers (US$3.581M)
Cap (US$)
PE
3.207M
—
Capital
TTM
5Y
10Y
Leveragex
0.706
0.227
0.156
EBIT/Intx
0.881
0.271
0.246
Own earn%
65.61
(65.39)
(31.24)
Sh yield%
32.30
40.23
40.47
Owners
Insiders/Inst%
7.73
81.62
Short interest%
3.57
SBC / revenue%
0.56
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
18–22
$1 testx
—
Incr. ROIC%
5